NCBI . NLM . NIH . GOV {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Ncbi.nlm.nih.gov Make Money
Keywords
Topics
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC2678035/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC2678035/. The analysis below is for the second page.

Title[redir]:
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis - PMC
Description:
Recent studies have suggested that mycophenolate mofetil (MMF) may offer advantages over intravenous cyclophosphamide (IVC) for the treatment of lupus nephritis, but these therapies have not been compared in an international randomized, controlled ...

Matching Content Categories {📚}

Insurance
Education
Science

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We can't figure out the monetization strategy.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Ncbi.nlm.nih.gov could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

patients, ivc, mmf, group, lupus, treatment, study, doi, pubmed, google, scholar, nephritis, hospital, groups, induction, renal, university, data, end, disease, response, therapy, medical, aes, aspreva, efficacy, dosage, cyclophosphamide, compared, mycophenolate, mofetil, studies, systemic, erythematosus, baseline, trial, received, class, table, center, primary, sle, race, phase, alms, rheum, controlled, point, urine, remission,

Topics {✒️}

systemic disease activity mandated steroid-tapering schedule columbia-presbyterian medical center harbor-ucla medical center pmc copyright notice hôpital bichat-claude bernard systemic lupus erythematosus sun yat-sen university supplementary materials included anti-dsdna antibody titer euro-lupus nephritis trial receive double-blinded mmf rheumatology damage index pmc beta search laiko general hospital secondary end points south/central america/caribbean urine protein/creatinine ratio open-label trial design roche-aspreva collaboration agreement racial/ethnic groups studied medical information department health science center centro medico integral ucla medical center license information pmcid primary end point hôpital de rangueil predicts poor survival rio de janeiro biológicas de sorocaba enrique de ramón de la cuesta de ramon garrido double-stranded dna hospital privado sa severe renal disease aspreva pharmaceuticals corporation pulse intravenous corticosteroids pulse methylprednisolone versus severe cardiovascular disease pulse immunosuppressive therapy proliferative lupus nephritis short-term induction therapy end point samples severe lupus nephritis safety assessments included predict disease outcome25 hospital peking university hôpital claude huriez

Social Networks {👍}(6)

External Links {🔗}(83)

Analytics and Tracking {📊}

Google Analytics
Google Analytics 4
Google Tag Manager

Libraries {📚}

jQuery
jQuery module (jquery-3.6.0)
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

nihcesxway.hub.nih.gov
nihcesxway2.hub.nih.gov
nihcesxway3.hub.nih.gov
nihcesxway4.hub.nih.gov
nihcesxway5.hub.nih.gov

Name Servers:

dns1-ncbi.ncbi.nlm.nih.gov
dns2-ncbi.ncbi.nlm.nih.gov
lhcns1.nlm.nih.gov
lhcns2.nlm.nih.gov

CDN Services {📦}

Ncbi

3.54s.